Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia
How to cite
Ain, Qurat Ul. 2024. "Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia." AEA RCT Registry. AEARCTR-0014083. https://doi.org/10.1257/rct.14083-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Neonatal hyperbilirubinemia is cause by raised serum total bilirubin levels usually manifests as jaundice and is commonly an indirect type.
There is a dearth of available in literature that illuminate the beneficial role of probiotics in
significantly reducing the total serum bilirubin. If the use of probiotics remarkably reduces the
serum bilirubin levels in neonatal hyperbilirubinemia, it would routinely be advised in the
future for newborns with neonatal jaundice. It would help reduce the side effects of
phototherapy, hospital admission, maternal-infant separation, and prolonged hospital
stays. Ultimately reducing the overall morbidity associated with neonatal hyperbilirubinemia.
The objective of the study is to compare the mean reduction in bilirubin and mean duration of neonatal hyperbilirubinemia
with probiotic and phototherapy in comparison with phototherapy alone.
Intervention
160 neonates, meeting the
selection criteria, admitted in Neonatal Intensive Care of the Pediatrics department at Pakistan Air Force
Hospital, Islamabad, will be enrolled in the study, after obtaining informed written consent from
parents/guardians. Demographic details like registration number, age,
gender, birth weight, gestational age at delivery, type of feeding, and serum total bilirubin level
at baseline will be noted. The neonates will be divided randomly into two groups by allocating
even numbers to Group A and odd numbers to Group B participants. In group A, neonates will
be given phototherapy along with oral probiotics (Enterogermina containing Bacillus Clausii –
2.5ml twice daily for 2 consecutive days) and group B will be given phototherapy by
consecutive non-probability sampling. The baseline STB level will be noted. Then neonates will
be followed-up for 12, 24, and 48 hours of treatment in the NICU. On each follow-up, a 2ml
blood sample will be taken in a red top serum vial and sent to the laboratory for assessment of
bilirubin level. STB will be assessed at 12, 24, and 48 hours of treatment and a reduction in
mean STB level at 12, 24, and 48 hours of treatment will be calculated from baseline (as per the
operational definition). Moreover, the effect of probiotics on the major clinical course including
the duration of phototherapy, duration of hospitalization, and the need for exchange transfusion
will be assessed. All the data will be collected by using the proforma. To reduce
selection bias within the study and maintain the quality of the data, the researcher along with
paramedical staff will collect and maintain all data.
Experimental design
Randomized control trial
Design details
Cited by
No citation data available for this registration yet.